Edition:
United States

Emergent BioSolutions Inc (EBS)

EBS on New York Consolidated

26.58USD
7 Dec 2016
Change (% chg)

$-1.20 (-4.30%)
Prev Close
$27.77
Open
$27.41
Day's High
$27.53
Day's Low
$26.27
Volume
301,889
Avg. Vol
484,558
52-wk High
$41.91
52-wk Low
$24.47

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Fuad El-Hibri

58 2012 Executive Chairman of the Board

Daniel Abdun-Nabi

61 2012 President, Chief Executive Officer, Director

Robert Kramer

58 2012 Executive Vice President - Corporate Services Division, Chief Financial Officer and Treasurer

Adam Havey

45 2011 Executive Vice President and President - BioDefense Division

Ronald Richard

60 2011 Lead Independent Director